DK1750765T3 - Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel - Google Patents

Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel

Info

Publication number: DK1750765T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical; antituberculous drug; antimycobacterial; composition; antimycobacterial composition
Prior art date: 2004-05-12

Application number

DK04816650T

Other languages

English (en)

Inventor

Sudershan Kumar Arora

Neelima Sinha

Rakesh Sinha

Ram Shankar Upadhyaya

Original Assignee

Lupin Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-12

Filing date

2004-08-27

Publication date

2008-01-28

2004-08-27 Application filed by Lupin Ltd filed Critical Lupin Ltd

2008-01-28 Application granted granted Critical

2008-01-28 Publication of DK1750765T3 publication Critical patent/DK1750765T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK04816650T 2004-05-12 2004-08-27 Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel DK1750765T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/844,992 US7491721B2 (en)	2004-05-12	2004-05-12	Antimycobacterial pharmaceutical composition
PCT/IN2004/000266 WO2005107809A2 (en)	2004-05-12	2004-08-27	Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Publications (1)

Publication Number	Publication Date
DK1750765T3 true DK1750765T3 (da)	2008-01-28

Family

ID=34960626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04816650T DK1750765T3 (da)	2004-05-12	2004-08-27	Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel

Country Status (44)

Country	Link
US (1)	US7491721B2 (da)
EP (1)	EP1750765B1 (da)
JP (1)	JP2007537242A (da)
KR (1)	KR100854309B1 (da)
CN (1)	CN1956732B (da)
AP (1)	AP1994A (da)
AR (1)	AR048948A1 (da)
AT (1)	ATE373488T1 (da)
AU (1)	AU2004319259A1 (da)
BR (1)	BRPI0418770A (da)
CA (1)	CA2566440C (da)
CR (1)	CR8748A (da)
DE (1)	DE602004009113T2 (da)
DK (1)	DK1750765T3 (da)
DO (1)	DOP2005000085A (da)
EA (1)	EA009694B1 (da)
EC (1)	ECSP066965A (da)
ES (1)	ES2294577T3 (da)
GE (1)	GEP20094805B (da)
HN (1)	HN2005000210A (da)
HR (1)	HRP20070574T3 (da)
IL (1)	IL178858A (da)
IS (1)	IS8559A (da)
JO (1)	JO2471B1 (da)
MA (1)	MA28603B1 (da)
MX (1)	MXPA06012984A (da)
MY (1)	MY139187A (da)
NI (1)	NI200600270A (da)
NO (1)	NO20065725L (da)
NZ (1)	NZ550892A (da)
PA (1)	PA8633001A1 (da)
PE (1)	PE20060353A1 (da)
PL (1)	PL1750765T3 (da)
PT (1)	PT1750765E (da)
RS (1)	RS20060624A (da)
SA (1)	SA05260130B1 (da)
SI (1)	SI1750765T1 (da)
SM (1)	SM200500011B (da)
SV (1)	SV2006002109A (da)
TN (1)	TNSN06349A1 (da)
UA (1)	UA82782C2 (da)
UY (1)	UY28893A1 (da)
WO (1)	WO2005107809A2 (da)
ZA (1)	ZA200608843B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2604388A1 (en) *	2005-04-11	2006-10-19	Lupin Limited	Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
JP5339840B2 (ja) *	2008-10-02	2013-11-13	公益財団法人微生物化学研究会	抗ｘｄｒ−ｔｂ薬、抗ｍｄｒ−ｔｂ薬、及び併用抗結核薬
US9198913B2 (en) *	2009-07-31	2015-12-01	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
WO2011031926A1 (en) *	2009-09-11	2011-03-17	Vertex Pharmaceuticals Incorporated	Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyridyl)-1-[2-[4-pyridyl)ethyl]propanamide and uses thereof
HUP1000033A2 (en) *	2010-01-21	2011-07-28	Uratim Kft	Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) *	2021-10-20	2022-11-03	순천향대학교 산학협력단	신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
CN117045657A (zh) *	2022-05-12	2023-11-14	广州嘉越医药科技有限公司	一种药物组合及其应用
US11977085B1 (en)	2023-09-05	2024-05-07	Elan Ehrlich	Date rape drug detection device and method of using same
CN118743705B (zh) *	2024-08-12	2024-11-15	深圳大学	药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5227383A (en) *	1991-06-14	1993-07-13	The University Of Mississippi	Compounds and compositions useful as antifungal and antimycobacterial agents
CN1668584A (zh) *	2002-09-20	2005-09-14	鲁宾有限公司	作为抗分支杆菌化合物的吡咯衍生物

2004
- 2004-05-12 US US10/844,992 patent/US7491721B2/en not_active Expired - Fee Related
- 2004-08-27 AT AT04816650T patent/ATE373488T1/de active
- 2004-08-27 DK DK04816650T patent/DK1750765T3/da active
- 2004-08-27 SI SI200430552T patent/SI1750765T1/sl unknown
- 2004-08-27 UA UAA200612258A patent/UA82782C2/uk unknown
- 2004-08-27 JP JP2007512723A patent/JP2007537242A/ja active Pending
- 2004-08-27 KR KR1020067023513A patent/KR100854309B1/ko not_active Expired - Fee Related
- 2004-08-27 AU AU2004319259A patent/AU2004319259A1/en not_active Abandoned
- 2004-08-27 RS YUP-2006/0624A patent/RS20060624A/sr unknown
- 2004-08-27 MX MXPA06012984A patent/MXPA06012984A/es active IP Right Grant
- 2004-08-27 EP EP04816650A patent/EP1750765B1/en not_active Expired - Lifetime
- 2004-08-27 EA EA200601952A patent/EA009694B1/ru not_active IP Right Cessation
- 2004-08-27 GE GEAP20049749A patent/GEP20094805B/en unknown
- 2004-08-27 BR BRPI0418770-9A patent/BRPI0418770A/pt not_active IP Right Cessation
- 2004-08-27 CN CN2004800431312A patent/CN1956732B/zh not_active Expired - Fee Related
- 2004-08-27 HR HR20070574T patent/HRP20070574T3/xx unknown
- 2004-08-27 WO PCT/IN2004/000266 patent/WO2005107809A2/en not_active Ceased
- 2004-08-27 DE DE602004009113T patent/DE602004009113T2/de not_active Expired - Lifetime
- 2004-08-27 CA CA002566440A patent/CA2566440C/en not_active Expired - Fee Related
- 2004-08-27 PT PT04816650T patent/PT1750765E/pt unknown
- 2004-08-27 ES ES04816650T patent/ES2294577T3/es not_active Expired - Lifetime
- 2004-08-27 NZ NZ550892A patent/NZ550892A/en unknown
- 2004-08-27 AP AP2006003807A patent/AP1994A/xx active
- 2004-08-27 PL PL04816650T patent/PL1750765T3/pl unknown
2005
- 2005-05-11 PE PE2005000526A patent/PE20060353A1/es not_active Application Discontinuation
- 2005-05-11 UY UY28893A patent/UY28893A1/es unknown
- 2005-05-11 AR ARP050101898A patent/AR048948A1/es not_active Application Discontinuation
- 2005-05-11 SV SV2005002109A patent/SV2006002109A/es not_active Application Discontinuation
- 2005-05-11 MY MYPI20052107A patent/MY139187A/en unknown
- 2005-05-11 DO DO2005000085A patent/DOP2005000085A/es unknown
- 2005-05-12 HN HN2005000210A patent/HN2005000210A/es unknown
- 2005-05-12 JO JO200559A patent/JO2471B1/en active
- 2005-05-12 PA PA20058633001A patent/PA8633001A1/es unknown
- 2005-05-12 SM SM200500011A patent/SM200500011B/it unknown
- 2005-05-14 SA SA5260130A patent/SA05260130B1/ar unknown
2006
- 2006-10-24 ZA ZA200608843A patent/ZA200608843B/xx unknown
- 2006-10-25 IL IL178858A patent/IL178858A/en not_active IP Right Cessation
- 2006-10-26 IS IS8559A patent/IS8559A/is unknown
- 2006-10-30 EC EC2006006965A patent/ECSP066965A/es unknown
- 2006-10-30 TN TNP2006000349A patent/TNSN06349A1/en unknown
- 2006-11-10 CR CR8748A patent/CR8748A/es not_active Application Discontinuation
- 2006-11-10 NI NI200600270A patent/NI200600270A/es unknown
- 2006-11-23 MA MA29484A patent/MA28603B1/fr unknown
- 2006-12-12 NO NO20065725A patent/NO20065725L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ECSP066965A (es)	2006-12-20
MY139187A (en)	2009-08-28
CN1956732A (zh)	2007-05-02
EA200601952A1 (ru)	2007-02-27
SM200500011A (it)	2005-11-16
ATE373488T1 (de)	2007-10-15
DE602004009113T2 (de)	2008-06-19
JO2471B1 (en)	2009-01-20
BRPI0418770A (pt)	2007-10-09
PT1750765E (pt)	2007-12-31
WO2005107809A8 (en)	2006-05-18
CR8748A (es)	2008-06-02
SM200500011B (it)	2005-11-16
MA28603B1 (fr)	2007-05-02
US20050256128A1 (en)	2005-11-17
WO2005107809A2 (en)	2005-11-17
EP1750765A2 (en)	2007-02-14
AP1994A (en)	2009-04-09
SI1750765T1 (sl)	2008-04-30
AR048948A1 (es)	2006-06-14
KR100854309B1 (ko)	2008-08-26
WO2005107809A3 (en)	2006-01-26
HRP20070574T3 (en)	2008-01-31
JP2007537242A (ja)	2007-12-20
HN2005000210A (es)	2009-03-17
CN1956732B (zh)	2010-04-28
UY28893A1 (es)	2005-12-30
GEP20094805B (en)	2009-10-26
NZ550892A (en)	2009-12-24
SV2006002109A (es)	2006-04-18
DE602004009113D1 (de)	2007-10-31
AP2006003807A0 (en)	2006-12-31
EP1750765B1 (en)	2007-09-19
EA009694B1 (ru)	2008-02-28
AU2004319259A1 (en)	2005-11-17
MXPA06012984A (es)	2007-04-23
SA05260130B1 (ar)	2008-05-04
NI200600270A (es)	2007-12-11
DOP2005000085A (es)	2007-01-15
IL178858A0 (en)	2007-03-08
CA2566440A1 (en)	2005-11-17
KR20070007920A (ko)	2007-01-16
IL178858A (en)	2010-06-16
PE20060353A1 (es)	2006-07-08
PA8633001A1 (es)	2006-12-07
HK1098962A1 (en)	2007-08-03
IS8559A (is)	2006-10-26
CA2566440C (en)	2009-08-04
NO20065725L (no)	2006-12-12
ZA200608843B (en)	2008-07-30
US7491721B2 (en)	2009-02-17
PL1750765T3 (pl)	2008-02-29
TNSN06349A1 (en)	2008-02-22
RS20060624A (sr)	2008-09-29
UA82782C2 (uk)	2008-05-12
ES2294577T3 (es)	2008-04-01

Publication	Publication Date	Title
CY2025003I1 (el)	2025-07-04	Λιποσωματα για τη χορηγηση φαρμακων
MA28489B1 (fr)	2007-03-01	Preparations pharmaceutiques
EP1620118A4 (en)	2010-08-04	REVERSIBLE PEGYLATED MEDICAMENTS
EP1513825A4 (en)	2011-01-05	ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
EP1748765A4 (en)	2009-11-18	Pharmaceutical suspension composition
DE502004003234D1 (de)	2007-04-26	Gegen missbrauch gesicherte darreichungsform
DE502004004205D1 (de)	2007-08-09	Gegen missbrauch gesicherte darreichungsform
DK1545662T3 (da)	2020-05-25	Lægemiddelindgivelsessystem
DE602005026188D1 (de)	2011-03-17	Medikamentenspender
DK1587478T3 (da)	2013-10-21	Farmaceutisk sammensætning
EP1919288A4 (en)	2009-12-16	MEDICAMENTS CONTAINING FAMOTIDINE AND IBUPROFEN, AND ADMINISTRATION OF SAID DRUGS
DK1750765T3 (da)	2008-01-28	Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
EP1718335A4 (en)	2010-11-10	drug conjugates
EP1750693A4 (en)	2010-06-02	OKULOSELECTIVE MEDICINAL PRODUCTS AND PRODRUGS
FR2870539B1 (fr)	2006-08-04	Nouvelles methodes et medicaments
EP1714648A4 (en)	2010-05-26	COMBINATION DRUGS
DK2918286T3 (da)	2020-03-30	En farmaceutisk formulering
ATE420118T1 (de)	2009-01-15	Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung
ITMI20041447A1 (it)	2004-10-20	Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it)	2004-08-11	Composizione farmaceutica cicatrizzante
EP1747205A4 (en)	2008-02-13	PHARMACEUTICAL COMPOSITIONS
CY1127305T1 (el)	2025-07-04	Λιποσωματα για τη χορηγηση φαρμακων
DK1653963T3 (da)	2007-04-10	Nasal farmaceutisk sammensætning piribedil
DE112004001429D2 (de)	2006-04-13	Pharmazeutischer Wirkstoff
UA8582S (uk)	2004-03-15	Ємність-туба для фармацевтичного засобу